Position in LKFT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,429,078
+$2,191,718 QoQ
Shares Held
181,090
+67.8% QoQ
Ownership
0.277%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 78 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LKFT Over Time
Shares Held
Position Value (USD)
Derivatives in LKFT
reported options exposure · as of Mar 31, 2023CallValue
$1,159,200
CallShares
30,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,595,539,054 across 322 Biotechnology names. LKFT ranks #163 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in LKFT
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,429,078 | 181,090 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,237,360 | 107,912 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,096,875 | 339,354 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,296,525 | 152,902 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,337,944 | 190,709 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,584,167 | 63,064 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,162,562 | 42,275 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,697,121 | 267,354 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,465,814 | 341,639 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,450,510 | 324,550 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,542,901 | 62,556 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $773,194 | 22,379 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,032,097 | 74,572 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,159,200 | 30,000 | Call | Sole | 2023-05-15 | |
| 2023-03-31 | $13,512,214 | 349,695 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,550,400 | 80,000 | Call | Sole | 2023-02-14 | |
| 2022-12-31 | $15,770,654 | 355,355 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,870,540 | 161,129 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,395,446 | 25,008 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $19,544,424 | 315,131 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $12,910,343 | 234,180 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $11,082,033 | 210,645 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $10,054,426 | 145,949 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $15,561,927 | 201,867 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $8,760,719 | 88,510 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,970,704 | 13,887 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,097,192 | 10,630 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,986,628 | 10,140 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||